AORT

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Artivion Inc

Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 100 countries worldwide.
CEO
James Mackin
Employees
1200
Headquarters

1655 Roberts Blvd NW
Kennesaw, Georgia 30144-3632
Phone: 17704193355
www.cryolife.com

News

Artivion Non-GAAP EPS of -$0.05, revenue of $76.8M
Nov 03, 2022 20:36pm

Artivion press release (AORT): Q3 Non-GAAP EPS of -$0.05.Revenue of $76.8M (+6.4% Y/Y).Full year revenues are now expected to be between $313.0 million and $316.0 million


Source:Seeking Alpha
This Senator Just Bought Up To $100K In Artivion Stock
Oct 18, 2022 17:03pm

The Office of Senator Tina Smith reported a purchase of Artivion (NYSE: AORT ) stock on October 17, 2022. According to the October filing, the transaction was made on October 17, 2022. What Happened: A Periodic Transaction Report from the U.S. Senate''s Office on October 17, 2022 showed that Smith bought $50,001 - $100,000 of Artivion stock. Artivion shares are trading down 0.7% at $10.92 at the time of writing. Why Congressional Transactions Matter Congressional transactions shouldn''t be used primarily to make an investing decision, however, they can be an important factor for an … Full story available on Benzinga.com


Source:Benzinga
Artivion: Stopping PROACT Xa Trial Removes Long-Term Growth Driver (NYSE:AORT)
Sep 27, 2022 21:48pm

Artivion''s decision to pull PROACT Xa trial resulted in heavy downside for its share price. Investors sold positions rapidly such that AORT stock trades at multi-year lows. Read more here.


Source:Seeking Alpha
Artivion Inc. PT Lowered to $28 at Lake Street Capital Markets
Sep 27, 2022 12:58pm

https://www.investing.com/news/pro/artivion-inc-pt-lowered-to-28-at-lake-street-capital-markets-432SI-2899854


Source:Investing.com